Corrected Carotid Flow Time for Predicting Spinal Anesthesia-induced Hypotension
Launched by SELCUK UNIVERSITY · Mar 25, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better predict low blood pressure (hypotension) that can happen during spinal anesthesia in pregnant women undergoing a cesarean section. Spinal anesthesia is a common method used for these surgeries, but it can sometimes cause problems like nausea and dizziness for the mother and can affect the baby as well. The researchers are looking at a technique called carotid artery Doppler, which measures blood flow in the neck, to see if it can help identify women who are at higher risk for low blood pressure after receiving spinal anesthesia.
To participate in this trial, women must be in their third trimester of a full-term pregnancy and have an overall good health status. However, those with certain medical conditions such as high blood pressure, diabetes, or heart problems, or who need an emergency cesarean section, will not be eligible. If you join the study, you can expect to have your blood flow measured and monitored during the procedure to help improve safety for you and your baby. This research aims to enhance our understanding of how to manage low blood pressure during cesarean sections, ultimately leading to better care for mothers and their newborns.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Full-term pregnancy
- • physical status II of American Society of Anesthesiologists
- Exclusion Criteria:
- • emergency cesarean section,
- • cesarean under general anesthesia
- • gestational Diabetes Mellitus
- • gestational Hypertension
- • preeclampsia,
- • cardiovascular disease
- • cerebrovascular disease
- • chronic kidney disease disease
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported